Immune Tolerance Induction (ITI) with a pdFVIII/VWF Concentrate (octanate) in 100 Patients in the Observational ITI (ObsITI) Study

Background  Immune tolerance induction (ITI) with repeated factor VIII (FVIII) administration is the only strategy proven to eradicate inhibitors. The observational ITI study is evaluating ITI with a range of FVIII products. Methods  This subgroup analysis reports prospective interim data for patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Escuriola Ettingshausen, Carmen, Vdovin, Vladimír, Zozulya, Nadezhda, Svirin, Pavel, Andreeva, Tatiana, Benedik-Dolničar, Majda, Jiménez-Yuste, Victor, Kitanovski, Lidija, Zupancic-Šalek, Silva, Pavlova, Anna, Bátorová, Angelika, Montaño Mejía, Cesar, Abdilova, Gulnara, Knaub, Sigurd, Jansen, Martina, Lowndes, Shannely, Belyanskaya, Larisa, Walter, Olaf, Oldenburg, Johannes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135478/
https://www.ncbi.nlm.nih.gov/pubmed/35707623
http://dx.doi.org/10.1055/s-0042-1748756

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135478/
https://www.ncbi.nlm.nih.gov/pubmed/35707623
http://dx.doi.org/10.1055/s-0042-1748756

Ejemplares similares